Somatostatin,_gastrin-releasing_peptide_and_gastrin_in_the_stomach_of_rats_with_streptozotocin-induced_diabetes_and_insulinoma._Somatostatin,_gastrin-releasing_peptide_(GRP)_and_gastrin_were_measured_in_the_stomach_of_rats_with_streptozotocin-induced_diabetes,_insulinoma-bearing_rats_and_their_respective_controls._Rats_injected_with_streptozotocin_exhibited_hyperphagia,_insulinopenia_and_severe_hyperglycemia._Stomach_weights,_and_the_concentrations_and_total_amounts_of_GRP_and_gastrin_in_the_stomach,_were_similar_to_nondiabetic_control_rats._The_concentration_of_somatostatin_in_the_stomach_of_diabetic_rats_was_25%_greater,_but_the_total_stomach_content_of_somatostatin_was_similar_to_that_of_control_rats._Insulinoma-bearing_rats_exhibited_hyperphagia,_hyperinsulinemia_and_hypoglycemia._Concentrations_of_GRP_and_gastrin_in_the_stomach_were_72%_and_19%_lower,_respectively,_than_in_control_rats._Despite_45%_greater_stomach_weight,_the_total_stomach_content_of_GRP_was_61%_lower._Stomach_concentrations_of_somatostatin,_and_total_stomach_contents_of_somatostatin_and_gastrin,_were_similar_in_insulinoma-bearing_and_control_rats._The_results_demonstrate_abnormalities_in_the_stomach_concentrations_of_regulatory_peptides_in_rats_with_diabetes_and_insulinoma._These_abnormalities_are_not_attributable_to_changes_in_food_intake_alone,_suggesting_specific_effects_of_these_metabolic_diseases_on_gastric_regulatory_peptides_and_gastric_function.